Quest’s COVID-19 testing programs provide the healthcare expertise you need to help your business and your clients get back on track. Our simple-to-execute, fully customizable solutions are focused on keeping travelers, groups, organizations, meetings, events and venues safe and healthy.

Straightforward test results and robust data reporting arm you and the public with the insights to make informed decisions about traveling or gathering in groups—even before being fully vaccinated.

Quest helps you design the right program for your unique needs

  • Consultation with a Quest specialist to assess goals and program needs
  • Customized program development and resource planning
  • Event implementation with rapid antigen testing
  • Reliable on-site results in 15-30 minutes for groups of almost any size
  • Public health reporting for community surveillance and screening
  • Follow-up for program evaluation

Get started now

Fill out the form below and one of our representatives will work with you to create a custom COVID-19 testing plan that can help you and your clients get back to everyday life.

*Indicates a required field

Our vast resources are dedicated to COVID-19 testing

Building illustration

A medical and scientific staff of more than 600 MDs and PHDs

Phone with texts illustration

A network of Quest locations across the country

Building illustration

Over 2,200 Patient Service Centers nationwide

Phone with texts illustration

47,000 team members committed to delivering diagnostic insights and supporting the efforts to fight COVID-19

Contact us to begin customizing your testing plan

START TODAY

COVID-19 testing statements

  • The antibody tests and the molecular tests (together “All tests”) have not been FDA cleared or approved;
  • All tests have been authorized by FDA under EUAs for use by authorized laboratories;
  • The antibody tests have been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;
  • The molecular tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens;
  • All tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner